Interesting news from across the globe, although the veracity of all stories from Russia and China is as always to be determined. More than 150 potential vaccines are being developed and tested globally, with 38 in human trials, and candidates from Moderna Inc, Pfizer Inc and AstraZeneca Plc are already in late-stage trials. Here we go:
Over 3000 Muscovites have been vaccinated, trials are over?
Earlier in Moscow, medical examinations began on the first people wishing to be vaccinated against coronavirus who applied to participate in a vaccine study
tass.com
Single dose Johnson & Johnson vaccine produces strong immune response
A single dose of Johnson & Johnson's <JNJ.N> experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results published on Friday.
www.reuters.com
Trial of new vaccine begins in UK
It is only the second vaccine to enter large scale trials in the UK and early signs suggest it can trigger an immune response.
www.bbc.co.uk
Covid antibodies endure over six months in China trial
The amount of Covid-19 antibodies in trial subjects who received China’s experimental vaccines remained high six months after the first shots, said a top Chinese scientist, projecting confidence that the country will be among the first to produce effective inoculation against the coronavirus.
www.bloomberg.com
Pakistan launches Phase 3 trials for Chinese developed vaccine
Pakistan has launched Phase III clinical trials for CanSino Biologics' COVID-19 vaccine candidate, a government minister and an official at the Chinese pharmaceutical company said on Tuesday.
www.reuters.com
India, worlds largest vaccine maker starts manufacturing Codagenix vaccine and promises, “India’s vaccine production and delivery capacity will be used to help all humanity in fighting this crisis.”
Codagenix Inc said on Tuesday Serum Institute of India has started manufacturing the U.S. biotech firm's potential COVID-19 vaccine and it expects to begin early-stage human trial of the vaccine by the end of 2020 in the UK.
www.reuters.com
Chinese firm expects vaccine approval within month
State-backed vaccine maker China National Biotec Group (CNBG) is hopeful of two of its novel coronavirus vaccine candidates receiving conditional regulatory approval for general public use within the year, its vice president said on Tuesday.
www.reuters.com